EP 2817029 B1 20190710 - METHODS FOR TREATING NON-SMALL CELL LUNG CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY
Title (en)
METHODS FOR TREATING NON-SMALL CELL LUNG CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY
Title (de)
VERFAHREN ZUR BEHANDLUNG VON NICHT KLEINZELLIGEN LUNGENKREBS MIT TOR KINASEHEMMERKOMBINATIONSTHERAPIE
Title (fr)
PROCÉDÉS DE TRAITEMENT DU CANCER DU POUMON NON À PETITES CELLULES À L'AIDE D'UNE THÉRAPIE COMBINÉE D'INHIBITEUR DE KINASE
Publication
Application
Priority
- US 201261603012 P 20120224
- US 201261716424 P 20121019
- US 201261725805 P 20121113
- US 2013027235 W 20130222
Abstract (en)
[origin: US2013225518A1] Provided herein are methods for treating or preventing advanced non-small cell lung cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount of erlotinib or a cytidine analog to a patient having advanced non-small cell lung cancer.
IPC 8 full level
A61K 45/06 (2006.01); A61K 31/437 (2006.01); A61K 31/4985 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); A61K 31/52 (2006.01); A61K 31/522 (2006.01); A61K 31/53 (2006.01); A61K 31/706 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP IL US)
A61K 31/437 (2013.01 - EP IL US); A61K 31/4985 (2013.01 - EP IL US); A61K 31/517 (2013.01 - EP IL US); A61K 31/519 (2013.01 - EP IL US); A61K 31/52 (2013.01 - EP IL US); A61K 31/522 (2013.01 - EP IL US); A61K 31/53 (2013.01 - EP IL US); A61K 31/706 (2013.01 - EP IL US); A61K 45/06 (2013.01 - EP IL US); A61P 11/00 (2017.12 - EP IL); A61P 35/00 (2017.12 - EP IL); A61P 43/00 (2017.12 - EP IL); A61K 2300/00 (2013.01 - IL)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
US 2013225518 A1 20130829; US 9375443 B2 20160628; AU 2013202305 A1 20130912; AU 2013202305 B2 20150312; BR 112014020786 A2 20201027; CA 2864905 A1 20130829; CN 104271159 A 20150107; CN 104271159 B 20171128; EA 028462 B1 20171130; EA 201491584 A1 20141230; EP 2817029 A1 20141231; EP 2817029 B1 20190710; ES 2742398 T3 20200214; HK 1199825 A1 20150724; IL 234169 B 20200630; IL 274647 A 20200630; JP 2015508103 A 20150316; JP 6114317 B2 20170412; KR 102064626 B1 20200109; KR 20140123112 A 20141021; MX 2014010198 A 20141121; MX 358303 B 20180814; MY 174308 A 20200406; NI 201400095 A 20161202; NZ 628410 A 20160331; PH 12014501880 A1 20141124; PH 12014501880 B1 20141124; PH 12017501500 A1 20181217; SG 11201405064R A 20140926; TW 201338778 A 20131001; TW I615143 B 20180221; WO 2013126636 A1 20130829; ZA 201406052 B 20151125
DOCDB simple family (application)
US 201313773686 A 20130222; AU 2013202305 A 20130222; BR 112014020786 A 20130222; CA 2864905 A 20130222; CN 201380021414 A 20130222; EA 201491584 A 20130222; EP 13707520 A 20130222; ES 13707520 T 20130222; HK 15100301 A 20150112; IL 23416914 A 20140818; IL 27464720 A 20200513; JP 2014558843 A 20130222; KR 20147026551 A 20130222; MX 2014010198 A 20130222; MY PI2014702320 A 20130222; NI 201400095 A 20140822; NZ 62841013 A 20130222; PH 12014501880 A 20140820; PH 12017501500 A 20170817; SG 11201405064R A 20130222; TW 102106348 A 20130222; US 2013027235 W 20130222; ZA 201406052 A 20140818